All lobbying filings

THE CONAFAY GROUP, LLC

THE CONAFAY GROUP, LLC filed a Q3 report for DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) on October 20, 2026, reporting $80,000 in lobbying income.

Lobbying for DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) · A clinical biopharmaceutical company developing products to treat brain health disorders.

All filings by THE CONAFAY GROUP, LLC · Everything DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Lobbyists on this filing 2

JOSH NARROW

Previously held: Intern to Sen. Casey
DARIN L GARDNER

Previously held: Legislative Correspondent Senator Tim Hutchinson;ResearchAssistant Senate HELP Committee; Chief ofStaffCongresswoman Kay Granger

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Education and advocacy for novel brain health treatments.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.